You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 120 No. 8, August 1985 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Postoperative Albumin Infusion Therapy Based on Colloid Osmotic Pressure

A Prospectively Randomized Trial

Reinhart Grundmann, MD; Sigrid Heistermann

Arch Surg. 1985;120(8):911-915.


Abstract

• In a prospectively randomized trial of 220 patients, 106 were given albumin when their colloid osmotic pressure (COP) fell below 24 cm H2O and 114 were given albumin when their COP fell below 29 cm H2O. There was no difference in the postoperative course between the two groups; however, by using the lower COP limit the postoperative albumin consumption in the intensive care unit was reduced significantly and thus the costs of treatment were lowered. In the case of extremely low COP, the prognosis of the disease worsened, indicating that the COP is of prognostic value. The albumin supply, however, did not influence the final outcome of the patients under these circumstances because it treated only a characteristic symptom and not the cause of the disease.

(Arch Surg 1985;120:911-915)



Author Affiliations

From the Chirurgische Universitätsklinik Köln-Lindenthal, Köln, West Germany.


Footnotes

Accepted for publication Nov 6, 1984.

Reprint requests to Chirurgische Universitätsklinik Köln-Lindenthal, Joseph-Stelzmann-Str 9, D-5000 Köln 41, West Germany (Prof Dr Grundmann).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Does giving albumin infusion in hypoalbuminaeimic children with oncological disease affect colloid osmotic pressure and outcome?1
Gupta and Tasker
Arch. Dis. Child. 2002;86 :380-381.
FULL TEXT  

Fluid Therapy in the Critically Ill Patient
Aber et al.
Journal of Pharmacy Practice 2002;15:114-123.
ABSTRACT  

Patient Survival after Human Albumin Administration: A Meta-Analysis of Randomized, Controlled Trials
Wilkes and Navickis
ANN INTERN MED 2001;135:149-164.
ABSTRACT | FULL TEXT  

The Good, the Bad, and the Ugly: Should We Completely Banish Human Albumin from Our Intensive Care Units?
Boldt
Anesth. Analg. 2000;91:887-895.
ABSTRACT | FULL TEXT  

The Use of Serum Albumin as a Prognostic or Nutritional Marker and The Pros and Cons of IV Albumin Therapy
Vanek
Nutr Clin Pract 1998;13:110-122.
ABSTRACT  

One Hundred Consecutive Hepatic Resections: Blood Loss, Transfusion, and Operative Technique
Cunningham et al.
Arch Surg 1994;129:1050-1056.
ABSTRACT  

The Therapeutic Use of Albumin
Hastings and Wolf
Arch Fam Med 1992;1:281-287.
ABSTRACT  

The Use of Albumin in Clinical Practice
Erstad et al.
Arch Intern Med 1991;151:901-911.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.